Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Parasite and host kinases as targets for antimalarials
Volume 27, Issue 2, February 2023, Page 151-169 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 21, 2023 Category: Drugs & Pharmacology Authors: Han Wee Ong Jack Adderley Andrew B. Tobin David H. Drewry Christian Doerig Source Type: research

Parasite and host kinases as targets for antimalarials
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 21, 2023 Category: Drugs & Pharmacology Authors: Han Wee Ong Jack Adderley Andrew B. Tobin David H. Drewry Christian Doerig Source Type: research

Targeting VCAM-1: a therapeutic opportunity for vascular damage
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 15, 2023 Category: Drugs & Pharmacology Authors: Mayarling F Troncoso Magda C D íaz-Vesga Fernanda Sanhueza-Olivares Jaime A Riquelme Marioly M üller Luis Garrido Luigi Gabrielli Mario Chiong Ramon Corbalan Pablo F Castro Sergio Lavandero Source Type: research

Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular level
Volume 27, Issue 2, February 2023, Page 133-149 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 6, 2023 Category: Drugs & Pharmacology Authors: John S Gibson David C Rees Source Type: research

Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular level
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 6, 2023 Category: Drugs & Pharmacology Authors: John S Gibson David C Rees Source Type: research

Recent advances of Phosphodiesterase 4B in cancer
Volume 27, Issue 2, February 2023, Page 121-132 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 28, 2023 Category: Drugs & Pharmacology Authors: Yu Miao Li Peng Zhaolin Chen Ying Hu Liangsong Tao Yan Yao Yincui Wu Dashuai Yang Tao Xu Source Type: research

Emerging therapeutic targets for osteoarthritis
Volume 27, Issue 2, February 2023, Page 111-120 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 28, 2023 Category: Drugs & Pharmacology Authors: Ermina Hadzic Frank Beier Source Type: research

Recent advances of Phosphodiesterase 4B in cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 28, 2023 Category: Drugs & Pharmacology Authors: Yu Miao Li Peng Zhaolin Chen Ying Hu Liangsong Tao Yan Yao Yincui Wu Dashuai Yang Tao Xu Source Type: research

Emerging therapeutic targets for osteoarthritis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 28, 2023 Category: Drugs & Pharmacology Authors: Ermina Hadzic Frank Beier Source Type: research

The case for complement component 5 as a target in neurodegenerative disease
Volume 27, Issue 2, February 2023, Page 97-109 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 17, 2023 Category: Drugs & Pharmacology Authors: Amelia Stennett Kallie Friston Claire L. Harris Adam J. M. Wollman Agnieszka K. Bronowska Katrina S. Madden Source Type: research

The case for complement component 5 as a target in neurodegenerative disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 17, 2023 Category: Drugs & Pharmacology Authors: Amelia Stennett Kallie Friston Claire L. Harris Adam J. M. Wollman Agnieszka K. Bronowska Katrina S. Madden Source Type: research

Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age
Volume 27, Issue 2, February 2023, Page 87-90 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 16, 2023 Category: Drugs & Pharmacology Authors: Mahmoud Abdellatif Frank Madeo Simon Sedej Guido Kroemer Source Type: research

Antagonistic pleiotropy: the example of cardiac insulin-like growth factor signaling, which is essential in youth but detrimental in age
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 16, 2023 Category: Drugs & Pharmacology Authors: Mahmoud Abdellatif Frank Madeo Simon Sedej Guido Kroemer Source Type: research

Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - February 16, 2023 Category: Drugs & Pharmacology Authors: Yanjie Huang Xueru Zhao Qiushuang Zhang Xiaoqing Yang Gailing Hou Chaoqun Peng Mengzhen Jia Li Zhou Tatsuo Yamamoto Jian Zheng Source Type: research